Ergebnisse einschränken

Targeting the DNA damage response for patients with lymphoma : preclinical and clinical evidences

Carrassa, Laura ; Colombo, Ilaria ; Damia, Giovanna ; Bertoni, Francesco

In: Cancer treatment reviews, 2020, vol. 90, p. 11

The DNA damage response (DDR) is a well-coordinated cellular network activated by DNA damage. The unravelling of the key players in DDR, their specific inactivation in different tumor types and the synthesis of specific chemical inhibitors of DDR represent a new hot topic in cancer therapy. In this article, we will review the importance of DDR in lymphoma development and how this can be...

Off-label use of thoracic aortic endovascular stent grafts to simplify difficult resections and procedures in general thoracic surgery

Walgram, Tanja ; Attigah, Nicolas ; Schwegler, Igor ; Weber, Markus ; Dzemali, Omer ; Berthold, Christian ; Wagnetz, Dirk ; Carboni, Giovanni L.

In: Interactive CardioVascular and Thoracic Surgery, 2018, vol. 26, no. 4, p. 545-550

Preclinical evaluation and test-retest studies of [18F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5)

Sephton, Selena ; Herde, Adrienne ; Mu, Linjing ; Keller, Claudia ; Rüdisühli, Sonja ; Auberson, Yves ; Schibli, Roger ; Krämer, Stefanie ; Ametamey, Simon

In: European Journal of Nuclear Medicine and Molecular Imaging, 2015, vol. 42, no. 1, p. 128-137

Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate

Müller, Cristina ; Reber, Josefine ; Haller, Stephanie ; Dorrer, Holger ; Bernhardt, Peter ; Zhernosekov, Konstantin ; Türler, Andreas ; Schibli, Roger

In: European Journal of Nuclear Medicine and Molecular Imaging, 2014, vol. 41, no. 3, p. 476-485

Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model

Grünberg, Jürgen ; Lindenblatt, Dennis ; Dorrer, Holger ; Cohrs, Susan ; Zhernosekov, Konstantin ; Köster, Ulli ; Türler, Andreas ; Fischer, Eliane ; Schibli, Roger

In: European Journal of Nuclear Medicine and Molecular Imaging, 2014, vol. 41, no. 10, p. 1907-1915

Treatment of Primary CNS Lymphoma

Roth, Patrick ; Stupp, Roger ; Eisele, Günter ; Weller, Michael

In: Current Treatment Options in Neurology, 2014, vol. 16, no. 1, p. 1-14

Imaging Tumour ATB0,+ Transport Activity by PET with the Cationic Amino Acid O -2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine

Müller, Adrienne ; Chiotellis, Aristeidis ; Keller, Claudia ; Ametamey, Simon ; Schibli, Roger ; Mu, Linjing ; Krämer, Stefanie

In: Molecular Imaging and Biology, 2014, vol. 16, no. 3, p. 412-420

Homology modeling and dynamics of the extracellular domain of rat and human neuronal nicotinic acetylcholine receptor subtypes α4β2 and α7

Bisson, William ; Westera, Gerrit ; Schubiger, P. ; Scapozza, Leonardo

In: Journal of Molecular Modeling, 2008, vol. 14, no. 10, p. 891-899

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

Antunes, P. ; Ginj, M. ; Zhang, H. ; Waser, B. ; Baum, R. ; Reubi, J. ; Maecke, H.

In: European Journal of Nuclear Medicine and Molecular Imaging, 2007, vol. 34, no. 7, p. 982-993

Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics

Antonescu, Cristian ; Bischof Delaloye, Angelika ; Kosinski, Marek ; Monnin, Pascal ; Schaffland, Andreas ; Ketterer, Nicolas ; Grannavel, Carine ; Kovacsovics, Tibor ; Verdun, Francis ; Buchegger, Franz

In: European Journal of Nuclear Medicine and Molecular Imaging, 2005, vol. 32, no. 8, p. 943-951